Document Detail


The combined administration of multiple soluble factors in the repair of chronically infarcted rat myocardium.
MedLine Citation:
PMID:  21383589     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The purpose of this study was to investigate a potential benefit of simultaneous administration of multiple soluble factors (SFs) in the repair of chronically infarcted rat myocardium. Rats subjected to a permanent coronary artery occlusion (myocardial infarction) received a cocktail of SF or a phosphate buffer. Four SFs, fibroblast growth factor-2 (2 μg), insulin-like growth factor-1 (1 μg), hepatocyte growth factor (2 μg), and stromal cell-derived factor-1α (0.6 μg) were injected directly into the ischemic myocardium at the onset of occlusion and subsequently at 3, 7, 14, and 21 days of surgery (intraperitoneally). Cardiac contractile function, infarct size and remodeling, and blood vessel density were studied at 4 weeks postsurgery. Infarct size, left ventricular circumference and cavity volume, thinning ratio, and expansion index were not statistically different between groups. Treatment of SF did not alter ejection fraction, compared with control. No statistical difference in total blood vessel density in the infarct zone was observed in SF versus control. In conclusion, our results that there were no enhancements in cardiac function, reductions in infarct size, improvements in remodeling, or increases in vasculature density in SF versus control do not support the study hypothesis that the combined use of multiple SF benefits the hearts with myocardial infarct.
Authors:
Hyosook Hwang; Robert A Kloner
Related Documents :
16769469 - Transthoracic ultrasound approach of thoracic aorta in critically ill patients with lun...
9120159 - Detection of chlamydia pneumoniae in human nonrheumatic stenotic aortic valves.
11805949 - The aortic elan stentless aortic valve: excellent hemodynamics and ease of implantation.
637599 - Transapical aortic perfusion with a double-barreled cannula.
15747039 - Quantification of aortic valve area and left ventricular muscle mass in healthy subject...
12776019 - Transesophageal echocardiographic evaluation of perioperative systolic murmur in aortic...
10894899 - Elevated cardiac troponin levels do not predict adverse outcomes in hospitalized patien...
743699 - Metabolic action and cellular structure of the myocardium during coronary angiography.
11792139 - Patients with acute coronary syndromes without persistent st elevation undergoing percu...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of cardiovascular pharmacology     Volume:  57     ISSN:  1533-4023     ISO Abbreviation:  J. Cardiovasc. Pharmacol.     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-03-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7902492     Medline TA:  J Cardiovasc Pharmacol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  282-6     Citation Subset:  IM    
Affiliation:
From the *Heart Institute, Good Samaritan Hospital, Los Angeles, CA; and †Division of Cardiovascular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of soluble epoxide hydrolase confers cardioprotection and prevents cardiac cytochrome P45...
Next Document:  Chronic nicotine exposure attenuates proangiogenic activity on human umbilical vein endothelial cell...